Technical Analysis for INZY - Inozyme Pharma, Inc.

Grade Last Price % Change Price Change
F 19.05 1.60% 0.30
INZY closed down 1.42 percent on Monday, April 12, 2021, on 48 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical INZY trend table...

Date Alert Name Type % Chg
Outside Day Range Expansion 1.60%
Down 3 Days in a Row Weakness 1.60%
Down 4 Days in a Row Weakness 1.60%
Narrow Range Bar Range Contraction 0.16%
NR7 Range Contraction 0.16%
Down 3 Days in a Row Weakness 0.16%
20 DMA Resistance Bearish -1.19%
Multiple of Ten Bearish Other -1.19%
Fell Below 20 DMA Bearish -4.75%
Fell Below 50 DMA Bearish -4.75%
Older End-of-Day Signals for INZY ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 2% 16 minutes ago
Down 2 % 36 minutes ago
Up 1% about 3 hours ago
60 Minute Opening Range Breakout about 5 hours ago
Down 1% about 6 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, as well as in the early stages of development for calciphylaxis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Biology Pharmaceutical Industry Disease Pharmacy Molecular Biology Specialty Drugs Genetic Disease Genetic Diseases Rare Genetic Disease Rare Genetic Diseases Recombinant Dna

Is INZY a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 31.6499
52 Week Low 16.1
Average Volume 73,233
200-Day Moving Average 0.00
50-Day Moving Average 20.44
20-Day Moving Average 19.91
10-Day Moving Average 19.58
Average True Range 1.36
ADX 11.91
+DI 19.08
-DI 21.51
Chandelier Exit (Long, 3 ATRs ) 18.89
Chandelier Exit (Short, 3 ATRs ) 21.62
Upper Bollinger Band 22.73
Lower Bollinger Band 17.09
Percent B (%b) 0.29
BandWidth 28.33
MACD Line -0.38
MACD Signal Line -0.39
MACD Histogram 0.0081
Fundamentals Value
Market Cap 438.24 Million
Num Shares 23.4 Million
EPS -1.11
Price-to-Earnings (P/E) Ratio -16.94
Price-to-Sales 0.00
Price-to-Book 3.65
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 20.19
Resistance 3 (R3) 20.29 19.91 19.95
Resistance 2 (R2) 19.91 19.54 19.86 19.87
Resistance 1 (R1) 19.33 19.32 19.14 19.23 19.79
Pivot Point 18.95 18.95 18.86 18.90 18.95
Support 1 (S1) 18.37 18.58 18.18 18.27 17.71
Support 2 (S2) 17.99 18.36 17.94 17.63
Support 3 (S3) 17.41 17.99 17.55
Support 4 (S4) 17.31